Cost effectiveness of multiple sclerosis drugs remains unknown.
R
R
MacDonald
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D007372:Interferons / Q000191:economics; D008727:Methotrexate / Q000191:economics; D009103:Multiple Sclerosis / Q000188:drug therapy*
D007372:Interferons; D008727:Methotrexate